Cognitive Market Research provides detailed analysis of Generic Injectables Market in our recently published report titled, "Generic Injectables Market 2020" The market study focuses on industry dynamics including driving factors to provide the key elements fueling the current market growth. The report also identifies restraints and opportunities to identify high growth segments involved in the Generic Injectables market. Key industrial factors such as macroeconomic and microeconomic factors are studied in detail with help of PESTEL analysis in order to have a holistic view of factors impacting Generic Injectables market growth across the globe. Market growth is forecasted with the help of complex algorithms such as regression analysis, sentiment analysis of end-users, etc.

1. 1
Global Generic Injectables Market 2020
Global Generic
Injectables
Market, 2020

2. 2
Global Generic Injectables Market 2020

3. 3
Global Generic Injectables Market 2020
Table of Content
Chapter 1 Generic Injectables Market Overview..............................14
1.1 Product Overview and Scope of Generic Injectables ....................................................14
1.2 Drivers, Restraints, and Opportunities for Global Generic Injectables Market: .............15
1.2.1 Drivers for Global Generic Injectables Market:.....................................................15
1.2.2 Restraints for Global Generic Injectables Market: ................................................15
1.2.3 Opportunities for Global Generic Injectables Market: ..........................................15
1.3 Generic Injectables Segment by Type..........................................................................16
1.3.1 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Comparison by Type (2014-2020).........................................................................16
1.3.2 Global Generic Injectables Revenue Market Share (%) by Type in 2018................17
1.3.3 Large Molecule Injectables (Biosimilars)...............................................................18
1.3.4 Small Molecule Injectables...................................................................................19
1.4 Generic Injectables Segment by Application................................................................20
1.4.1 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Comparison by Application (2014-2020)...............................................................20
1.4.2 Global Generic Injectables Revenue Market Share (%) by Application in
2018.....................................................................................................................21
1.4.3 Oncology..............................................................................................................22
1.4.4 Infectious Diseases...............................................................................................23
1.4.5 Cardiology............................................................................................................24
1.4.6 Diabetes...............................................................................................................25
1.4.7 Immunology.........................................................................................................26
1.4.8 Others..................................................................................................................27
1.5 Global Generic Injectables Market by Regions (2014-2020)..........................................28
1.5.1 Global Generic Injectables Market Size and Growth Rate (%) Comparison
by Regions (2014-2020)........................................................................................28
1.5.2 North America Generic Injectables Status and Prospect (2014-2027)....................30
1.5.3 Europe Generic Injectables Status and Prospect (2014-2027) ...............................31

4. 4
Global Generic Injectables Market 2020
1.5.4 Asia Pacific Generic Injectables Status and Prospect (2014-2027).........................32
1.5.5 Latin America Generic Injectables Status and Prospect (2014-2027).....................33
1.5.6 Middle East and Africa Generic Injectables Status and Prospect (2014-
2027) ...................................................................................................................34
1.6 Global Generic Injectables Market Size (2014-2027) ....................................................35
1.6.1 Global Generic Injectables Revenue Status and Outlook (2014-2027)...................35
Chapter 2 Global Generic Injectables Market Competition by
Manufacturers (Subject To Data Availability).................36
2.1 Global Generic Injectables Revenue and Share by Manufacturers (2014-2018).............36
Chapter 3 Executive Summary...........................................................39
3.1 Global Generic Injectables Market, 2014 – 2027, (USD Million)....................................39
3.2 Global Generic Injectables Market: Snapshot ..............................................................40
Chapter 4 COVID – 19 Impact Analysis on Generic
Injectables Market..............................................................41
4.1 Generic Injectables Market – COVID – 19 Impact Analysis............................................41
4.2 Global Generic Injectables Market – PESTEL Analysis...................................................42
4.3 Global Generic Injectables Market – Porters Five Forces Analysis.................................43
Chapter 5 Global Generic Injectables Sales by Regions
(2014-2020)..........................................................................44
5.1 Global Generic Injectables Revenue and Market Share (%) by Regions (2014-
2020) .........................................................................................................................44
Chapter 6 North America Generic Injectables Market
Development Status and Outlook....................................47
6.1.1 North America Generic Injectables Market by Country, 2014-2020 ......................47
6.2 North America Generic Injectables Market Size (2014-2020)........................................47
6.2.1 North America Generic Injectables Market (USD Million) Size by Type
(2014-2020)..........................................................................................................49
6.2.2 North America Generic Injectables Market (USD Million) Size by
Application (2014-2020).......................................................................................50
Chapter 7 Europe Generic Injectables Market Development
Status and Outlook ............................................................51
7.1.1 Europe Generic Injectables Market by Country, 2014-2020 ..................................51

5. 5
Global Generic Injectables Market 2020
7.2 Europe Generic Injectables Market Size (2014-2020) ...................................................51
7.2.1 Europe Generic Injectables Market (USD Million) Size by Type (2014-2020) .........53
7.2.2 Europe Generic Injectables Market (USD Million) Size by Application
(2014-2020)..........................................................................................................54
Chapter 8 Asia Pacific Generic Injectables Market
Development Status and Outlook....................................55
8.1.1 Asia Pacific Generic Injectables Market by Country, 2014-2020............................55
8.2 Asia Pacific Generic Injectables Market Size (2014-2020).............................................55
8.2.1 Asia Pacific Generic Injectables Market (USD Million) Size by Type (2014-
2020) ...................................................................................................................57
8.2.2 Asia Pacific Generic Injectables Market (USD Million) Size by Application
(2014-2020)..........................................................................................................58
Chapter 9 Latin America Generic Injectables Market
Development Status and Outlook....................................59
9.1.1 Latin America Generic Injectables Market by Country, 2014-2020........................59
9.2 Latin America Generic Injectables Market Size (2014-2020) .........................................59
9.2.1 Latin America Generic Injectables Market (USD Million) Size by Type
(2014-2020)..........................................................................................................61
9.2.2 Latin America Generic Injectables Market (USD Million) Size by
Application (2014-2020).......................................................................................62
Chapter 10 Middle East and Africa Generic Injectables Market
Development Status and Outlook....................................63
10.1.1 Middle East and Africa Generic Injectables Market by Country, 2014-2020 ..........63
10.2 Middle East and Africa Generic Injectables Market Size (2014-2020)............................63
10.2.1 Middle East and Africa Generic Injectables Market (USD Million) Size by
Type (2014-2020) .................................................................................................65
10.2.2 Middle East and Africa Generic Injectables Market (USD Million) Size by
Application (2014-2020).......................................................................................66
Chapter 11 Global Generic Injectables Market Revenue (Value)
by Type................................................................................67
11.1 Global Generic Injectables Revenue and Market Share (%) by Type (2014-2020) ..........67

6. 6
Global Generic Injectables Market 2020
Chapter 12 Global Generic Injectables Market Revenue (Value)
by Application.....................................................................70
12.1 Global Generic Injectables Revenue and Market Share (%) by Application (2014-
2020) .........................................................................................................................70
Chapter 13 Global Generic Injectables Manufacturers
Profiles/Analysis ................................................................73
13.1 Pfizer .........................................................................................................................73
13.1.1 Pfizer Basic Information, Manufacturing Base, SalesArea and its
Competitors.........................................................................................................73
13.1.2 Generic Injectables Types Specification................................................................74
13.1.3 Main Business/Business Overview.......................................................................75
13.2 Novartis AG (Sandoz International GmbH) ..................................................................76
13.3 Baxter........................................................................................................................76
13.4 Fresenius ...................................................................................................................76
13.5 Mylan ........................................................................................................................76
13.6 Teva Pharmaceutical ..................................................................................................76
13.7 Hikma Pharmaceuticals ..............................................................................................76
13.8 Lupin..........................................................................................................................76
13.9 Sanofi ........................................................................................................................76
13.10 Biocon........................................................................................................................76
13.11 Aurobindo Pharma.....................................................................................................76
13.12 Sagent Pharmaceuticals..............................................................................................77
13.13 Zydus Cadila...............................................................................................................77
13.14 GlaxoSmithKline.........................................................................................................77
13.15 AstraZeneca...............................................................................................................77
Chapter 14 Generic Injectables Manufacturing Cost Analysis ........78
14.1 Proportion of Manufacturing Cost Structure ...............................................................78
14.1.1 Raw Materials......................................................................................................78
14.1.2 Labor Cost............................................................................................................78
14.1.3 USA Labor CostAnalysis........................................................................................78
14.1.4 EU Labor Costs Analysis........................................................................................79
14.1.5 China Labor Costs Analysis...................................................................................79
14.1.6 Manufacturing Expenses......................................................................................79

7. 7
Global Generic Injectables Market 2020
Chapter 15 Market Effect Factors Analysis ........................................80
15.1 Consumer Needs/Customer Preference Change ..........................................................80
15.2 Economic/Political Environmental Change ..................................................................80
Chapter 16 Global Generic Injectables Market Forecast (2020-
2027).....................................................................................82
16.1 Global Generic Injectables Revenue Forecast (2020-2027) ...........................................82
16.1.1 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Forecast (2020-2027)............................................................................................82
16.2 Global Generic Injectables Revenue (USD Million) Forecast by Regions (2020-
2027) .........................................................................................................................83
16.2.1 North America Generic Injectables Revenue (USD Million) Forecast (2020-
2027) ...................................................................................................................84
16.2.2 Europe Generic Injectables Revenue (USD Million) Forecast (2020-2027).............84
16.2.3 Asia Pacific Generic Injectables Revenue (USD Million) Forecast (2020-
2027) ...................................................................................................................85
16.2.4 Latin America Generic Injectables Revenue (USD Million) Forecast (2020-
2027) ...................................................................................................................86
16.2.5 Middle East and Africa Generic Injectables Revenue (USD Million) Forecast
(2020-2027)..........................................................................................................86
16.3 Global Generic Injectables Revenue and Forecast by Type (2020-2027)........................88
16.4 Global Generic Injectables Revenue and Forecast by Application (2020-2027)..............88
Chapter 17 North America Generic Injectables Market
Forecast 2020-2027............................................................91
17.1 North America............................................................................................................91
17.1.1 North America Generic Injectables Market by Country, 2020-2027 ......................91
17.1.2 North America Generic Injectables Market Size (2020-2027)................................91
17.1.3 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)..........................................................................................................92
17.1.4 North America Generic Injectables Revenue Market Size by Type 2022................92
17.1.5 North America Generic Injectables Market (USD Million) Size by
Application (2020-2027).......................................................................................93
17.1.6 North America Generic Injectables Revenue Market Size by Application
2022.....................................................................................................................93

8. 8
Global Generic Injectables Market 2020
Chapter 18 Europe Generic Injectables Market Forecast 2020-
2027......................................................................................95
18.1 Europe.......................................................................................................................95
18.1.1 Europe Generic Injectables Market by Country, 2020-2027 ..................................95
18.1.2 Europe Generic Injectables Market Size (2020-2027)............................................95
18.1.3 Europe Generic Injectables Market (USD Million) Size by Type (2020-2027) .........96
18.1.4 Europe Generic Injectables Revenue Market Size by Type 2022 ...........................96
18.1.5 Europe Generic Injectables Market (USD Million) Size by Application
(2020-2027)..........................................................................................................97
18.1.6 Europe Generic Injectables Revenue Market Size by Application 2022 .................97
Chapter 19 Asia Pacific Generic Injectables Market Forecast
2020-2027 ............................................................................99
19.1 Asia Pacific.................................................................................................................99
19.1.1 Asia Pacific Generic Injectables Market by Country, 2020-2027............................99
19.1.2 Asia Pacific Generic Injectables Market Size (2020-2027)......................................99
19.1.3 Asia Pacific Generic Injectables Market (USD Million) Size by Type (2020-
2027) .................................................................................................................100
19.1.4 Asia Pacific Generic Injectables Revenue Market Size by Type 2022 ...................100
19.1.5 Asia Pacific Generic Injectables Market (USD Million) Size by Application
(2020-2027)........................................................................................................101
19.1.6 Asia Pacific Generic Injectables Revenue Market Size by Application 2022.........101
Chapter 20 Latin America Generic Injectables Market Forecast
2020-2027 ......................................................................... 103
20.1 Latin America...........................................................................................................103
20.1.1 Latin America Generic Injectables Market by Country, 2020-2027......................103
20.1.2 Latin America Generic Injectables Market Size (2020-2027) ...............................103
20.1.3 Latin America Generic Injectables Market (USD Million) Size by Type
(2020-2027)........................................................................................................104
20.1.4 Latin America Generic Injectables Revenue Market Size by Type 2022 ...............104
20.1.5 Latin America Generic Injectables Market (USD Million) Size by
Application (2020-2027).....................................................................................105
20.1.6 Latin America Generic Injectables Revenue Market Size by Application
2022...................................................................................................................105

9. 9
Global Generic Injectables Market 2020
Chapter 21 Middle East and Africa Generic Injectables Market
Forecast 2020-2027......................................................... 107
21.1 Middle East and Africa..............................................................................................107
21.1.1 Middle East and Africa Generic Injectables Market by Country, 2020-2027 ........107
21.1.2 Middle East and Africa Generic Injectables Market Size (2020-2027)..................107
21.1.3 Middle East and Africa Generic Injectables Market (USD Million) Size by
Type (2020-2027) ...............................................................................................108
21.1.4 Middle East and Africa Generic Injectables Revenue Market Size by Type
2022...................................................................................................................108
21.1.5 Middle East and Africa Generic Injectables Market (USD Million) Size by
Application (2020-2027).....................................................................................109
21.1.6 Middle East and Africa Generic Injectables Revenue Market Size by
Application 2022................................................................................................109
Chapter 22 Research Findings and Conclusion ............................. 111

10. 10
Global Generic Injectables Market 2020
List of Figures
FIG. 1 Product Picture of Generic Injectables 14
FIG. 2 Global Generic Injectables Revenue Market Share (%) by Type in 2018 17
FIG. 3 Global Large Molecule Injectables (Biosimilars) Market Revenue (USD Million) and
Growth Rate (%), (2014 – 2027) 18
FIG. 4 Global Small Molecule Injectables Market Revenue (USD Million) and Growth Rate
(%), (2014 – 2027) 19
FIG. 5 Global Generic Injectables Revenue Market Share (%) by Application in 2018 21
FIG. 6 Global Oncology Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 22
FIG. 7 Global Infectious Diseases Market Revenue (USD Million) and Growth Rate (%),
(2014 – 2027) 23
FIG. 8 Global Cardiology Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 24
FIG. 9 Global Diabetes Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 25
FIG. 10 Global Immunology Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 26
FIG. 11 Global Others Market Revenue (USD Million) and Growth Rate (%), (2014 – 2027) 27
FIG. 12 Global Generic Injectables Market Size Comparison and Growth Rate (%) by
Regions (2014-2020) 28
FIG. 13 North America Generic Injectables Revenue (USD Million) and Growth Rate (2014-
2027) 30
FIG. 14 Europe Generic Injectables Revenue (USD Million) and Growth Rate (2014-2027) 31
FIG. 15 Asia Pacific Generic Injectables Revenue (USD Million) and Growth Rate (2014-
2027) 32
FIG. 16 Latin America Generic Injectables Revenue (USD Million) and Growth Rate (2014-
2027) 33
FIG. 17 Middle East and Africa Generic Injectables Revenue (USD Million) and Growth
Rate (2014-2027) 34
FIG. 18 Global Generic Injectables Revenue (USD Million) Status and Outlook (2014-2027) 35
FIG. 19 2018 Global Generic Injectables Revenue Share by Manufacturers 38
FIG. 20 Global Generic Injectables Market, 2014 – 2027, (USD Million) 39
FIG. 21 Global Generic Injectables Market – PESTEL Analysis 42
FIG. 22 Porter’s five forces analysis 43
FIG. 23 Global Generic Injectables Revenue Market Share (%) by Regions (2014-2020) 45
FIG. 24 Global Generic Injectables Revenue Market Share (%) by Regions, 2018 46
FIG. 25 North America Generic Injectables Market Share (%) by Country (2014-2020) 47
FIG. 26 North America Generic Injectables Market Size by Type 2017 49
FIG. 27 North America Generic Injectables Market Size by Application 2017 50
FIG. 28 Europe Generic Injectables Market Share (%) by Country (2014-2020) 51
FIG. 29 Europe Generic Injectables Market Size by Type 2017 53

11. 11
Global Generic Injectables Market 2020
FIG. 30 Europe Generic Injectables Market Size by Application 2017 54
FIG. 31 Asia Pacific Generic Injectables Market Share (%) by Country (2014-2020) 55
FIG. 32 Asia Pacific Generic Injectables Market Size by Type 2017 57
FIG. 33 Asia Pacific Generic Injectables Market Size by Application 2017 58
FIG. 34 Latin America Generic Injectables Market Share (%) by Country (2014-2020) 59
FIG. 35 Latin America Generic Injectables Market Size by Type 2017 61
FIG. 36 Latin America Generic Injectables Market Size by Application 2017 62
FIG. 37 Middle East and Africa Generic Injectables Market Share (%) by Country (2014-
2020) 63
FIG. 38 Middle East and Africa Generic Injectables Market Size by Type 2017 65
FIG. 39 Middle East and Africa Generic Injectables Market Size by Application 2017 66
FIG. 40 Global Generic Injectables Market Revenue Share (%) by Type (2014-2020) 68
FIG. 41 2018 Revenue Market Share (%) of Generic Injectables by Type 69
FIG. 42 Global Generic Injectables Market Revenue Share (%) by Application (2014-2020) 71
FIG. 43 2018 Revenue Market Share (%) of Generic Injectables by Application 72
FIG. 44 Pfizer Revenue Market Share (%) (2014-2018) 75
FIG. 45 Manufacturing Cost Structure of Generic Injectables 78
FIG. 46 Economic/Political Environmental Change 80
FIG. 47 Global Generic Injectables Revenue (USD Million) and Growth Rate (%) Forecast
(2020-2027) 82
FIG. 48 Global Generic Injectables Revenue (USD Million) Market Share (%) Forecast by
Regions (2020-2027) 83
FIG. 49 North America Generic Injectables Revenue (USD Million) and Growth Rate (%)
Forecast (2020-2027) 84
FIG. 50 Europe Generic Injectables Revenue (USD Million) and Growth Rate (%) Forecast
(2020-2027) 84
FIG. 51 Asia Pacific Generic Injectables Revenue (USD Million) and Growth Rate (%)
Forecast (2020-2027) 85
FIG. 52 Latin America Generic Injectables Revenue (USD Million) and Growth Rate (%)
Forecast (2020-2027) 86
FIG. 53 Middle East and Africa Generic Injectables Revenue (USD Million) and Growth
Rate (%) Forecast (2020-2027) 86
FIG. 54 Global Generic Injectables Revenue Market Share (%) Forecast by Type (2020-
2027) 88
FIG. 55 Global Generic Injectables Revenue Market Share (%) Forecast by Application
(2020-2027) 89
FIG. 56 North America Generic Injectables Market Share (%) by Country (2020-2027) 91
FIG. 57 North America Generic Injectables Revenue Market Size by Type 2022 92
FIG. 58 North America Generic Injectables Revenue Market Size by Application 2022 93
FIG. 59 Europe Generic Injectables Market Share (%) by Country (2020-2027) 95
FIG. 60 Europe Generic Injectables Revenue Market Size by Type 2022 96
FIG. 61 Europe Generic Injectables Revenue Market Size by Application 2022 97

12. 12
Global Generic Injectables Market 2020
FIG. 62 Asia Pacific Generic Injectables Market Share (%) by Country (2020-2027) 99
FIG. 63 Asia Pacific Generic Injectables Revenue Market Size by Type 2022 100
FIG. 64 Asia Pacific Generic Injectables Revenue Market Size by Application 2022 101
FIG. 65 Latin America Generic Injectables Market Share (%) by Country (2020-2027) 103
FIG. 66 Latin America Generic Injectables Revenue Market Size by Type 2022 104
FIG. 67 Latin America Generic Injectables Revenue Market Size by Application 2022 105
FIG. 68 Middle East and Africa Generic Injectables Market Share (%) by Country (2020-
2027) 107
FIG. 69 Middle East and Africa Generic Injectables Revenue Market Size by Type 2022 108
FIG. 70 Middle East and Africa Generic Injectables Revenue Market Size by Application
2022 109
List of Tables
TABLE 1 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Comparison by Type (2014-2019) 16
TABLE 2 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Comparison by Application (2014-2019) 20
TABLE 3 Generic Injectables Market Revenue (USD Million) Comparison by Regions (2014-
2027) 29
TABLE 4 Global Generic Injectables Revenue (USD Million) by Manufacturers (2014-2018) 36
TABLE 5 Global Generic Injectables Revenue Share by Manufacturers (2014-2018) 37
TABLE 6 Market Snapshot 40
TABLE 7 Global Generic Injectables Revenue (USD Million) by Regions (2014-2020) 44
TABLE 8 Global Generic Injectables Revenue Market Share (%) by Regions (2014-2020) 44
TABLE 9 North America Generic Injectables Market by Country Revenue, 2014-2020 47
TABLE 10 North America Generic Injectables Market (USD Million) Size by Type (2014-2020) 49
TABLE 11 North America Generic Injectables Market (USD Million) Size by Application (2014-
2020) 50
TABLE 12 Europe Generic Injectables Market by Country Revenue, 2014-2020 51
TABLE 13 Europe Generic Injectables Market (USD Million) Size by Type (2014-2020) 53
TABLE 14 Europe Generic Injectables Market (USD Million) Size by Application (2014-2020) 54
TABLE 15 Asia Pacific Generic Injectables Market by Country Revenue, 2014-2020 55
TABLE 16 Asia Pacific Generic Injectables Market (USD Million) Size by Type (2014-2020) 57
TABLE 17 Asia Pacific Generic Injectables Market (USD Million) Size by Application (2014-
2020) 58
TABLE 18 Latin America Generic Injectables Market by Country Revenue, 2014-2020 59
TABLE 19 Latin America Generic Injectables Market (USD Million) Size by Type (2014-2020) 61
TABLE 20 Latin America Generic Injectables Market (USD Million) Size by Application (2014-
2020) 62

13. 13
Global Generic Injectables Market 2020
TABLE 21 Middle East and Africa Generic Injectables Market by Country Revenue, 2014-
2020 63
TABLE 22 Middle East and Africa Generic Injectables Market (USD Million) Size by Type
(2014-2020) 65
TABLE 23 Middle East and Africa Generic Injectables Market (USD Million) Size by
Application (2014-2020) 66
TABLE 24 Global Generic Injectables Revenue (USD Million) by Type (2014-2020) 67
TABLE 25 Global Generic Injectables Revenue Share (%) by Type (2014-2020) 67
TABLE 26 Global Generic Injectables Revenue (USD Million) by Application (2014-2020) 70
TABLE 27 Global Generic Injectables Revenue Share (%) by Type (2014-2020) 70
TABLE 28 Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors 73
TABLE 29 Pfizer Revenue (USD Million), Gross Margin (%) and Market Share (%) (2014-
2018) 74
TABLE 30 Global Generic Injectables Revenue (USD Million) Forecast by Regions (2020-
2027) 83
TABLE 31 Global Generic Injectables Revenue (USD Million) Forecast by Type (2020-2027) 88
TABLE 32 Global Generic Injectables Revenue (USD Million) Forecast by Application (2020-
2027) 88
TABLE 33 North America Generic Injectables Market by Country Revenue, 2020-2027 91
TABLE 34 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 92
TABLE 35 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 93
TABLE 36 Europe Generic Injectables Market by Country Revenue, 2020-2027 95
TABLE 37 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 96
TABLE 38 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 97
TABLE 39 Asia Pacific Generic Injectables Market by Country Revenue, 2020-2027 99
TABLE 40 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 100
TABLE 41 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 101
TABLE 42 Latin America Generic Injectables Market by Country Revenue, 2020-2027 103
TABLE 43 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 104
TABLE 44 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 105
TABLE 45 Middle East and Africa Generic Injectables Market by Country Revenue, 2020-
2027 107
TABLE 46 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 108
TABLE 47 North America Generic Injectables Market (USD Million) Size by Type (2020-2027) 109

14. 14
Global Generic Injectables Market 2020
Chapter 1 Generic Injectables Market Overview
1.1 Product Overview and Scope of Generic Injectables
FIG. 1 Product Picture of Generic Injectables

15. 15
Global Generic Injectables Market 2020
1.2 Drivers, Restraints, and Opportunities for Global Generic
Injectables Market:
1.2.1 Drivers for Global Generic Injectables Market:
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
1.2.2 Restraints for Global Generic Injectables Market:
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
1.2.3 Opportunities for Global Generic Injectables Market:
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

16. 16
Global Generic Injectables Market 2020
1.3 Generic Injectables Segment by Type
1.3.1 Global Generic Injectables Revenue (USD Million) and
Growth Rate (%) Comparison by Type (2014-2020)
TABLE 1 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Comparison by Type (2014-2019)
Market Segment Type 2014 2015 2016 2017 2018 2019
Large Molecule
Injectables
(Biosimilars)
xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Small Molecule
Injectables
xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Total xx xx xx xx xx xx
-YOY (%) xx xx xx xx xx xx

17. 17
Global Generic Injectables Market 2020
1.3.2 Global Generic Injectables Revenue Market Share (%)
by Type in 2018
FIG. 2 Global Generic Injectables Revenue Market Share (%) by Type
in 2018
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis

18. 18
Global Generic Injectables Market 2020
1.3.3 Large Molecule Injectables (Biosimilars)
In 2014, the Large Molecule Injectables (Biosimilars) Revenue (USD Million) was
USD xx Million and it expected to reach at USD xx Million in 2027
FIG. 3 Global Large Molecule Injectables (Biosimilars) Market
Revenue (USD Million) and Growth Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

19. 19
Global Generic Injectables Market 2020
1.3.4 Small Molecule Injectables
In 2014, the Small Molecule Injectables Revenue (USD Million) was USD xx Million
and it expected to reach at USD xx Million in 2027
FIG. 4 Global Small Molecule Injectables Market Revenue (USD
Million) and Growth Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

20. 20
Global Generic Injectables Market 2020
1.4 Generic Injectables Segment by Application
1.4.1 Global Generic Injectables Revenue (USD Million) and
Growth Rate (%) Comparison by Application (2014-
2020)
TABLE 2 Global Generic Injectables Revenue (USD Million) and Growth Rate (%)
Comparison by Application (2014-2019)
Market Segment Type 2014 2015 2016 2017 2018 2019
Oncology xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Cardiology xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Diabetes xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Immunology xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Others xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Total xx xx xx xx xx xx
-YOY (%) xx xx xx xx xx xx

21. 21
Global Generic Injectables Market 2020
1.4.2 Global Generic Injectables Revenue Market Share (%)
by Application in 2018
FIG. 5 Global Generic Injectables Revenue Market Share (%) by
Application in 2018
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis

22. 22
Global Generic Injectables Market 2020
1.4.3 Oncology
In 2014, the Oncology Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 6 Global Oncology Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

23. 23
Global Generic Injectables Market 2020
1.4.4 Infectious Diseases
In 2014, the Infectious Diseases Revenue (USD Million) was USD xx Million and it
expected to reach at USD xx Million in 2027
FIG. 7 Global Infectious Diseases Market Revenue (USD Million) and
Growth Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

24. 24
Global Generic Injectables Market 2020
1.4.5 Cardiology
In 2014, the Cardiology Revenue (USD Million) was USD xx Million and it expected
to reach at USD xx Million in 2027
FIG. 8 Global Cardiology Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

25. 25
Global Generic Injectables Market 2020
1.4.6 Diabetes
In 2014, the Diabetes Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 9 Global Diabetes Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

26. 26
Global Generic Injectables Market 2020
1.4.7 Immunology
In 2014, the Immunology Revenue (USD Million) was USD xx Million and it
expected to reach at USD xx Million in 2027
FIG. 10 Global Immunology Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

27. 27
Global Generic Injectables Market 2020
1.4.8 Others
In 2014, the Others Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 11 Global Others Market Revenue (USD Million) and Growth Rate
(%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

28. 28
Global Generic Injectables Market 2020
1.5 Global Generic Injectables Market by Regions (2014-2020)
1.5.1 Global Generic Injectables Market Size and Growth
Rate (%) Comparison by Regions (2014-2020)
FIG. 12 Global Generic Injectables Market Size Comparison and
Growth Rate (%) by Regions (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

29. 29
Global Generic Injectables Market 2020
TABLE 3 Generic Injectables Market Revenue (USD Million) Comparison by
Regions (2014-2027)
Region 2014 2019 2027 Market
Share
(%)
2027
CAGR (%)
(2019-2027)
North America xx xx xx xx Xx
Europe xx xx xx xx Xx
Asia Pacific xx xx xx xx Xx
Latin America xx xx xx xx Xx
Middle East and Africa xx xx xx xx Xx
Total xx xx xx xx xx

30. 30
Global Generic Injectables Market 2020
1.5.2 North America Generic Injectables Status and Prospect
(2014-2027)
The North America Generic Injectables market size was USD xx Million in 2014 and
it will be USD xx Million in 2027.
FIG. 13 North America Generic Injectables Revenue (USD Million) and
Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

31. 31
Global Generic Injectables Market 2020
1.5.3 Europe Generic Injectables Status and Prospect (2014-
2027)
The North America Generic Injectables market size was USD xx Million in 2014 and
it will be USD xx Million in 2027.
FIG. 14 Europe Generic Injectables Revenue (USD Million) and Growth
Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

32. 32
Global Generic Injectables Market 2020
1.5.4 Asia Pacific Generic Injectables Status and Prospect
(2014-2027)
The North America Generic Injectables market size was USD xx Million in 2014 and
it will be USD xx Million in 2027.
FIG. 15 Asia Pacific Generic Injectables Revenue (USD Million) and
Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

33. 33
Global Generic Injectables Market 2020
1.5.5 Latin America Generic Injectables Status and Prospect
(2014-2027)
The North America Generic Injectables market size was USD xx Million in 2014 and
it will be USD xx Million in 2027.
FIG. 16 Latin America Generic Injectables Revenue (USD Million) and
Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

34. 34
Global Generic Injectables Market 2020
1.5.6 Middle East and Africa Generic Injectables Status and
Prospect (2014-2027)
The North America Generic Injectables market size was USD xx Million in 2014 and
it will be USD xx Million in 2027.
FIG. 17 Middle East and Africa Generic Injectables Revenue (USD
Million) and Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

35. 35
Global Generic Injectables Market 2020
1.6 Global Generic Injectables Market Size (2014-2027)
1.6.1 Global Generic Injectables Revenue Status and Outlook
(2014-2027)
The global Generic Injectables Market is valued at USD xx Million in 2014 and is
expected to reach USD xx Million by the end of 2027.
FIG. 18 Global Generic Injectables Revenue (USD Million) Status and
Outlook (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

36. 36
Global Generic Injectables Market 2020
Chapter 2 Global Generic Injectables Market Competition by
Manufacturers (Subject To Data Availability)
2.1 Global Generic Injectables Revenue and Share by
Manufacturers (2014-2018)
TABLE 4 Global Generic Injectables Revenue (USD Million) by Manufacturers
(2014-2018)
Manufacturers 2014 2015 2016 2017 2018
Pfizer xx xx xx xx Xx
Novartis AG (Sandoz International GmbH) xx xx xx xx Xx
Baxter xx xx xx xx Xx
Fresenius xx xx xx xx Xx
Mylan xx xx xx xx Xx
Teva Pharmaceutical xx xx xx xx Xx
Hikma Pharmaceuticals xx xx xx xx Xx
Lupin xx xx xx xx Xx
Sanofi xx xx xx xx Xx
Biocon xx xx xx xx Xx
Aurobindo Pharma xx xx xx xx Xx
Sagent Pharmaceuticals xx xx xx xx Xx
Zydus Cadila xx xx xx xx Xx
GlaxoSmithKline xx xx xx xx Xx
AstraZeneca xx xx xx xx Xx

37. 37
Global Generic Injectables Market 2020
TABLE 5 Global Generic Injectables Revenue Share by Manufacturers (2014-2018)
Manufacturers 2014 2015 2016 2017 2018
Pfizer xx xx xx xx Xx
Novartis AG (Sandoz International GmbH) xx xx xx xx Xx
Baxter xx xx xx xx Xx
Fresenius xx xx xx xx Xx
Mylan xx xx xx xx Xx
Teva Pharmaceutical xx xx xx xx Xx
Hikma Pharmaceuticals xx xx xx xx Xx
Lupin xx xx xx xx Xx
Sanofi xx xx xx xx Xx
Biocon xx xx xx xx Xx
Aurobindo Pharma xx xx xx xx Xx
Sagent Pharmaceuticals xx xx xx xx Xx
Zydus Cadila xx xx xx xx Xx
GlaxoSmithKline xx xx xx xx Xx
AstraZeneca xx xx xx xx Xx

38. 38
Global Generic Injectables Market 2020
FIG. 19 2018 Global Generic Injectables Revenue Share by
Manufacturers
Source: Secondary Research, Interviews, and Expert Analysis

39. 39
Global Generic Injectables Market 2020
Chapter 3 Executive Summary
The global Generic Injectables Market is valued at USD xx Million in 2014 and is
expected to reach USD xx Million by the end of 2027, growing at a CAGR of xx%
between 2019 and 2027.
3.1 Global Generic Injectables Market, 2014 – 2027, (USD
Million)
FIG. 20 Global Generic Injectables Market, 2014 – 2027, (USD Million)
Source: Secondary Research, Interviews, and Expert Analysis
XX
XX2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
GrowthRate%
Revenue(USDMillion)
Revenue Growth Rate

40. 40
Global Generic Injectables Market 2020
3.2 Global Generic Injectables Market: Snapshot
TABLE 6 Market Snapshot
Generic
Injectables
Market
2014 2020
Global
Revenue
(USD
Million)
xx xx
CAGR (2019
– 2025)
xx%
Key Type
Segment
(Revenue
Share)
Large Molecule Injectables
(Biosimilars):xx%
Small Molecule Injectables:xx%
Large Molecule Injectables
(Biosimilars):xx%
Small Molecule Injectables:xx%
Key
Application
Segment
(Revenue
Share)
Oncology:xx%
Infectious Diseases:xx%
Cardiology:xx%
Diabetes:xx%
Immunology:xx%
Others:xx%
Oncology:xx%
Infectious Diseases:xx%
Cardiology:xx%
Diabetes:xx%
Immunology:xx%
Others:xx%
Key Regional
Segment
(Revenue
Share)
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
Middle East and Africa: xx%
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
Middle East and Africa: xx%
Driver xxxxxxxxxxxxxxxx
Restraint xxxxxxxxxxxxxxxx
Opportunity xxxxxxxxxxxxxxxx

41. 41
Global Generic Injectables Market 2020
Chapter 4 COVID – 19 Impact Analysis on Generic
Injectables Market
4.1 Generic Injectables Market – COVID – 19 Impact Analysis
An analysis of the market developments between December 2019 to till date
revealed that product commercialization, developmental collaborations, and product
distribution partnerships were adopted by market players to maintain a competitive
position in the Generic Injectables market to mitigate the COVID-19 impact.
Product commercialization was the most widely adopted growth strategy.
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

42. 42
Global Generic Injectables Market 2020
4.2 Global Generic Injectables Market – PESTEL Analysis
FIG. 21 Global Generic Injectables Market – PESTEL Analysis
Source: Secondary Research, Interviews, and Expert Analysis
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
PESTLE
Economic
Social
Legal
Enviornmental
Technological
Political

43. 43
Global Generic Injectables Market 2020
4.3 Global Generic Injectables Market – Porters Five Forces
Analysis
FIG. 22 Porter’s five forces analysis
Source: Secondary Research, Interviews, and Expert Analysis

44. 44
Global Generic Injectables Market 2020
Chapter 5 Global Generic Injectables Sales by Regions
(2014-2020)
5.1 Global Generic Injectables Revenue and Market Share (%)
by Regions (2014-2020)
TABLE 7 Global Generic Injectables Revenue (USD Million) by Regions (2014-
2020)
2014 2015 2016 2017 2018 2019 2020
North America xx xx xx xx xx xx Xx
Europe xx xx xx xx xx xx Xx
Asia Pacific xx xx xx xx xx xx Xx
Latin America xx xx xx xx xx xx Xx
Middle East and Africa xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
TABLE 8 Global Generic Injectables Revenue Market Share (%) by Regions (2014-
2020)
2014 2015 2016 2017 2018 2019 2020
North America xx xx xx xx xx xx Xx
Europe xx xx xx xx xx xx Xx
Asia Pacific xx xx xx xx xx xx Xx
Latin America xx xx xx xx xx xx Xx
Middle East and Africa xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx

45. 45
Global Generic Injectables Market 2020
FIG. 23 Global Generic Injectables Revenue Market Share (%) by
Regions (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

46. 46
Global Generic Injectables Market 2020
FIG. 24 Global Generic Injectables Revenue Market Share (%) by
Regions, 2018
Source: Secondary Research, Interviews, and Expert Analysis

47. 47
Global Generic Injectables Market 2020
Chapter 6 North America Generic Injectables Market
Development Status and Outlook
6.1.1 North America Generic Injectables Market by Country,
2014-2020
TABLE 9 North America Generic Injectables Market by Country Revenue, 2014-
2020
2014 2015 2016 2017 2018 2019 2020
U.S. xx xx xx xx xx xx Xx
Canada xx xx xx xx xx xx Xx
Mexico xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
6.2 North America Generic Injectables Market Size (2014-2020)
FIG. 25 North America Generic Injectables Market Share (%) by
Country (2014-2020)

48. 48
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

49. 49
Global Generic Injectables Market 2020
6.2.1 North America Generic Injectables Market (USD
Million) Size by Type (2014-2020)
TABLE 10 North America Generic Injectables Market (USD Million) Size by Type
(2014-2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 26 North America Generic Injectables Market Size by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

50. 50
Global Generic Injectables Market 2020
6.2.2 North America Generic Injectables Market (USD
Million) Size by Application (2014-2020)
TABLE 11 North America Generic Injectables Market (USD Million) Size by
Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 27 North America Generic Injectables Market Size by Application
2017
Source: Secondary Research, Interviews, and Expert Analysis

51. 51
Global Generic Injectables Market 2020
Chapter 7 Europe Generic Injectables Market Development
Status and Outlook
7.1.1 Europe Generic Injectables Market by Country, 2014-
2020
TABLE 12 Europe Generic Injectables Market by Country Revenue, 2014-2020
2014 2015 2016 2017 2018 2019 2020
UK xx xx xx xx xx xx Xx
France xx xx xx xx xx xx Xx
Germany xx xx xx xx xx xx Xx
Italy xx xx xx xx xx xx Xx
Russia xx xx xx xx xx xx Xx
Spain xx xx xx xx xx xx Xx
Rest of Europe xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
7.2 Europe Generic Injectables Market Size (2014-2020)
FIG. 28 Europe Generic Injectables Market Share (%) by Country
(2014-2020)

52. 52
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

53. 53
Global Generic Injectables Market 2020
7.2.1 Europe Generic Injectables Market (USD Million) Size
by Type (2014-2020)
TABLE 13 Europe Generic Injectables Market (USD Million) Size by Type (2014-
2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 29 Europe Generic Injectables Market Size by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

54. 54
Global Generic Injectables Market 2020
7.2.2 Europe Generic Injectables Market (USD Million) Size
by Application (2014-2020)
TABLE 14 Europe Generic Injectables Market (USD Million) Size by Application
(2014-2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 30 Europe Generic Injectables Market Size by Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

55. 55
Global Generic Injectables Market 2020
Chapter 8 Asia Pacific Generic Injectables Market
Development Status and Outlook
8.1.1 Asia Pacific Generic Injectables Market by Country,
2014-2020
TABLE 15 Asia Pacific Generic Injectables Market by Country Revenue, 2014-2020
2014 2015 2016 2017 2018 2019 2020
China xx xx xx xx xx xx Xx
Japan xx xx xx xx xx xx Xx
India xx xx xx xx xx xx Xx
Korea xx xx xx xx xx xx Xx
South East Asia xx xx xx xx xx xx Xx
Rest of APAC xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
8.2 Asia Pacific Generic Injectables Market Size (2014-2020)
FIG. 31 Asia Pacific Generic Injectables Market Share (%) by Country
(2014-2020)

56. 56
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

57. 57
Global Generic Injectables Market 2020
8.2.1 Asia Pacific Generic Injectables Market (USD Million)
Size by Type (2014-2020)
TABLE 16 Asia Pacific Generic Injectables Market (USD Million) Size by Type (2014-
2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 32 Asia Pacific Generic Injectables Market Size by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

58. 58
Global Generic Injectables Market 2020
8.2.2 Asia Pacific Generic Injectables Market (USD Million)
Size by Application (2014-2020)
TABLE 17 Asia Pacific Generic Injectables Market (USD Million) Size by Application
(2014-2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 33 Asia Pacific Generic Injectables Market Size by Application
2017
Source: Secondary Research, Interviews, and Expert Analysis

59. 59
Global Generic Injectables Market 2020
Chapter 9 Latin America Generic Injectables Market
Development Status and Outlook
9.1.1 Latin America Generic Injectables Market by Country,
2014-2020
TABLE 18 Latin America Generic Injectables Market by Country Revenue, 2014-
2020
2014 2015 2016 2017 2018 2019 2020
Brazil xx xx xx xx xx xx Xx
Argentina xx xx xx xx xx xx Xx
Columbia xx xx xx xx xx xx Xx
Rest of Latin America xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
9.2 Latin America Generic Injectables Market Size (2014-2020)
FIG. 34 Latin America Generic Injectables Market Share (%) by
Country (2014-2020)

60. 60
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

61. 61
Global Generic Injectables Market 2020
9.2.1 Latin America Generic Injectables Market (USD
Million) Size by Type (2014-2020)
TABLE 19 Latin America Generic Injectables Market (USD Million) Size by Type
(2014-2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 35 Latin America Generic Injectables Market Size by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

62. 62
Global Generic Injectables Market 2020
9.2.2 Latin America Generic Injectables Market (USD
Million) Size by Application (2014-2020)
TABLE 20 Latin America Generic Injectables Market (USD Million) Size by
Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 36 Latin America Generic Injectables Market Size by Application
2017
Source: Secondary Research, Interviews, and Expert Analysis

63. 63
Global Generic Injectables Market 2020
Chapter 10 Middle East and Africa Generic Injectables Market
Development Status and Outlook
10.1.1 Middle East and Africa Generic Injectables Market by
Country, 2014-2020
TABLE 21 Middle East and Africa Generic Injectables Market by Country Revenue,
2014-2020
2014 2015 2016 2017 2018 2019 2020
GCC Countries xx xx xx xx xx xx Xx
Egypt xx xx xx xx xx xx Xx
South Africa xx xx xx xx xx xx Xx
Nigeria xx xx xx xx xx xx Xx
Turkey xx xx xx xx xx xx Xx
Rest of MEA xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
10.2 Middle East and Africa Generic Injectables Market Size
(2014-2020)
FIG. 37 Middle East and Africa Generic Injectables Market Share (%)
by Country (2014-2020)

64. 64
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

65. 65
Global Generic Injectables Market 2020
10.2.1 Middle East and Africa Generic Injectables Market
(USD Million) Size by Type (2014-2020)
TABLE 22 Middle East and Africa Generic Injectables Market (USD Million) Size by
Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 38 Middle East and Africa Generic Injectables Market Size by Type
2017
Source: Secondary Research, Interviews, and Expert Analysis

66. 66
Global Generic Injectables Market 2020
10.2.2 Middle East and Africa Generic Injectables Market
(USD Million) Size by Application (2014-2020)
TABLE 23 Middle East and Africa Generic Injectables Market (USD Million) Size by
Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 39 Middle East and Africa Generic Injectables Market Size by
Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

67. 67
Global Generic Injectables Market 2020
Chapter 11 Global Generic Injectables Market Revenue
(Value) by Type
11.1 Global Generic Injectables Revenue and Market Share (%)
by Type (2014-2020)
TABLE 24 Global Generic Injectables Revenue (USD Million) by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
TABLE 25 Global Generic Injectables Revenue Share (%) by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Large Molecule Injectables (Biosimilars) xx xx xx xx xx Xx Xx
Small Molecule Injectables xx xx xx xx xx Xx Xx
Total xx xx xx xx xx xx xx

68. 68
Global Generic Injectables Market 2020
FIG. 40 Global Generic Injectables Market Revenue Share (%) by Type
(2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

69. 69
Global Generic Injectables Market 2020
FIG. 41 2018 Revenue Market Share (%) of Generic Injectables by
Type
Source: Secondary Research, Interviews, and Expert Analysis

70. 70
Global Generic Injectables Market 2020
Chapter 12 Global Generic Injectables Market Revenue
(Value) by Application
12.1 Global Generic Injectables Revenue and Market Share (%)
by Application (2014-2020)
TABLE 26 Global Generic Injectables Revenue (USD Million) by Application (2014-
2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
TABLE 27 Global Generic Injectables Revenue Share (%) by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Oncology xx xx xx xx xx Xx Xx
Infectious Diseases xx xx xx xx xx Xx Xx
Cardiology xx xx xx xx xx Xx Xx
Diabetes xx xx xx xx xx Xx Xx
Immunology xx xx xx xx xx Xx Xx
Others xx xx xx xx xx Xx Xx
Total xx xx xx xx xx xx xx

71. 71
Global Generic Injectables Market 2020
FIG. 42 Global Generic Injectables Market Revenue Share (%) by
Application (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

72. 72
Global Generic Injectables Market 2020
FIG. 43 2018 Revenue Market Share (%) of Generic Injectables by
Application
Source: Secondary Research, Interviews, and Expert Analysis

73. 73
Global Generic Injectables Market 2020
Chapter 13 Global Generic Injectables Manufacturers
Profiles/Analysis
13.1 Pfizer
13.1.1 Pfizer Basic Information, Manufacturing Base, Sales Area
and its Competitors
TABLE 28 Pfizer Basic Information, Manufacturing Base, Sales Area and Its
Competitors
# Item Description
1 Company Name Pfizer
2 Website xx
Established Date xx
4 Headquartered xx
6 Market Position or History xx
8 Contact Information xx

74. 74
Global Generic Injectables Market 2020
13.1.2 Generic Injectables Types Specification
Type Type Picture
xx xx
xx xx
xx xx
xx xx
xx xx
TABLE 29 Pfizer Revenue (USD Million), Gross Margin (%) and Market Share (%)
(2014-2018)
Value 2014 2015 2016 2017 2018
Revenue xx xx xx xx xx
Gross Margin xx xx xx xx xx

75. 75
Global Generic Injectables Market 2020
FIG. 44 Pfizer Revenue Market Share (%) (2014-2018)
Source: Secondary Research, Interviews, and Expert Analysis
13.1.3 Main Business/Business Overview
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.

76. 76
Global Generic Injectables Market 2020
13.2 Novartis AG (Sandoz International GmbH)
13.3 Baxter
13.4 Fresenius
13.5 Mylan
13.6 Teva Pharmaceutical
13.7 Hikma Pharmaceuticals
13.8 Lupin
13.9 Sanofi
13.10 Biocon
13.11 Aurobindo Pharma

77. 77
Global Generic Injectables Market 2020
13.12 Sagent Pharmaceuticals
13.13 Zydus Cadila
13.14 GlaxoSmithKline
13.15 AstraZeneca
Kindly note company revenue will be subject to data available

78. 78
Global Generic Injectables Market 2020
Chapter 14 Generic Injectables Manufacturing Cost Analysis
14.1 Proportion of Manufacturing Cost Structure
FIG. 45 Manufacturing Cost Structure of Generic Injectables
Source: Secondary Research, Interviews, and Expert Analysis
14.1.1 Raw Materials
xxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
14.1.2 Labor Cost
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
14.1.3 USA Labor Cost Analysis
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

79. 79
Global Generic Injectables Market 2020
14.1.4 EU Labor Costs Analysis
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX.
14.1.5 China Labor Costs Analysis
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
14.1.6 Manufacturing Expenses
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

80. 80
Global Generic Injectables Market 2020
Chapter 15 Market Effect Factors Analysis
15.1 Consumer Needs/Customer Preference Change
XXXXXXXXXXXXXXXXXXXXX.
15.2 Economic/Political Environmental Change
FIG. 46 Economic/Political Environmental Change
Source: Secondary Research, Interviews, and Expert Analysis
U.S.
Shifting direction of policy
Europe
Economic activity in Western Europe will remain subdued
Africa
Growth to recover
moderately amid
challenges
East Asia
Domestic demand
continues to drive positive
near-term outlook amid
weak export performance
Japan
Policy easing supports
short-term prospects
Latin America and the
Caribbean
Return to positive growth in
2017, but strong external and
internal headwinds persist

81. 81
Global Generic Injectables Market 2020
U.S.
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Europe
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Japan
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Africa
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
East Asia
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Latin America and the Caribbean
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

82. 82
Global Generic Injectables Market 2020
Chapter 16 Global Generic Injectables Market Forecast
(2020-2027)
16.1 Global Generic Injectables Revenue Forecast (2020-2027)
16.1.1 Global Generic Injectables Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027)
FIG. 47 Global Generic Injectables Revenue (USD Million) and Growth
Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
xx
xx
xx
xx
xx
xx
xx
xx
xx
2020 2021 2022 2023 2024 2025 2026 2027
GrowthRate%
Revenue(USDMillion)
Revenue Growth Rate

83. 83
Global Generic Injectables Market 2020
16.2 Global Generic Injectables Revenue (USD Million) Forecast
by Regions (2020-2027)
TABLE 30 Global Generic Injectables Revenue (USD Million) Forecast by Regions
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
North America XX XX XX XX XX XX XX XX
Europe XX XX XX XX XX XX XX XX
Asia Pacific XX XX XX XX XX XX XX XX
Latin America XX XX XX XX XX XX XX XX
Middle East and Africa XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
FIG. 48 Global Generic Injectables Revenue (USD Million) Market
Share (%) Forecast by Regions (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis

84. 84
Global Generic Injectables Market 2020
16.2.1 North America Generic Injectables Revenue (USD
Million) Forecast (2020-2027)
FIG. 49 North America Generic Injectables Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
16.2.2 Europe Generic Injectables Revenue (USD Million)
Forecast (2020-2027)
FIG. 50 Europe Generic Injectables Revenue (USD Million) and Growth
Rate (%) Forecast (2020-2027)

85. 85
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
16.2.3 Asia Pacific Generic Injectables Revenue (USD Million)
Forecast (2020-2027)
FIG. 51 Asia Pacific Generic Injectables Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis

86. 86
Global Generic Injectables Market 2020
16.2.4 Latin America Generic Injectables Revenue (USD
Million) Forecast (2020-2027)
FIG. 52 Latin America Generic Injectables Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
16.2.5 Middle East and Africa Generic Injectables Revenue
(USD Million) Forecast (2020-2027)
FIG. 53 Middle East and Africa Generic Injectables Revenue (USD
Million) and Growth Rate (%) Forecast (2020-2027)

87. 87
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

88. 88
Global Generic Injectables Market 2020
16.3 Global Generic Injectables Revenue and Forecast by Type
(2020-2027)
TABLE 31 Global Generic Injectables Revenue (USD Million) Forecast by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Large Molecule
Injectables
(Biosimilars)
XX XX XX XX XX XX XX XX
Small Molecule
Injectables
XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
FIG. 54 Global Generic Injectables Revenue Market Share (%)
Forecast by Type (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
16.4 Global Generic Injectables Revenue and Forecast by
Application (2020-2027)
TABLE 32 Global Generic Injectables Revenue (USD Million) Forecast by
Application (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027

89. 89
Global Generic Injectables Market 2020
Oncology XX XX XX XX XX XX XX XX
Infectious
Diseases
XX XX XX XX XX XX XX XX
Cardiology XX XX XX XX XX XX XX XX
Diabetes XX XX XX XX XX XX XX XX
Immunology XX XX XX XX XX XX XX XX
Others XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
FIG. 55 Global Generic Injectables Revenue Market Share (%)
Forecast by Application (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis

90. 90
Global Generic Injectables Market 2020

91. 91
Global Generic Injectables Market 2020
Chapter 17 North America Generic Injectables Market
Forecast 2020-2027
17.1 North America
17.1.1 North America Generic Injectables Market by Country,
2020-2027
TABLE 33 North America Generic Injectables Market by Country Revenue, 2020-
2027
2020 2021 2022 2023 2024 2025 2026 2027
U.S. XX XX XX XX XX XX XX XX
Canada XX XX XX XX XX XX XX XX
Mexico XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
17.1.2 North America Generic Injectables Market Size (2020-
2027)
FIG. 56 North America Generic Injectables Market Share (%) by
Country (2020-2027)

92. 92
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
17.1.3 North America Generic Injectables Market (USD
Million) Size by Type (2020-2027)
TABLE 34 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
17.1.4 North America Generic Injectables Revenue Market
Size by Type 2022
FIG. 57 North America Generic Injectables Revenue Market Size by
Type 2022

93. 93
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
17.1.5 North America Generic Injectables Market (USD
Million) Size by Application (2020-2027)
TABLE 35 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Oncology xx xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
17.1.6 North America Generic Injectables Revenue Market
Size by Application 2022
FIG. 58 North America Generic Injectables Revenue Market Size by
Application 2022

94. 94
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

95. 95
Global Generic Injectables Market 2020
Chapter 18 Europe Generic Injectables Market Forecast
2020-2027
18.1 Europe
18.1.1 Europe Generic Injectables Market by Country, 2020-
2027
TABLE 36 Europe Generic Injectables Market by Country Revenue, 2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
UK XX XX XX XX XX XX XX XX
France XX XX XX XX XX XX XX XX
Germany XX XX XX XX XX XX XX XX
Italy XX XX XX XX XX XX XX XX
Russia XX XX XX XX XX XX XX XX
Spain XX XX XX XX XX XX XX XX
Rest of Europe XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
18.1.2 Europe Generic Injectables Market Size (2020-2027)
FIG. 59 Europe Generic Injectables Market Share (%) by Country
(2020-2027)

96. 96
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
18.1.3 Europe Generic Injectables Market (USD Million) Size
by Type (2020-2027)
TABLE 37 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
18.1.4 Europe Generic Injectables Revenue Market Size by
Type 2022
FIG. 60 Europe Generic Injectables Revenue Market Size by Type 2022

97. 97
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
18.1.5 Europe Generic Injectables Market (USD Million) Size
by Application (2020-2027)
TABLE 38 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Oncology xx xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
18.1.6 Europe Generic Injectables Revenue Market Size by
Application 2022
FIG. 61 Europe Generic Injectables Revenue Market Size by
Application 2022

98. 98
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

99. 99
Global Generic Injectables Market 2020
Chapter 19 Asia Pacific Generic Injectables Market Forecast
2020-2027
19.1 Asia Pacific
19.1.1 Asia Pacific Generic Injectables Market by Country,
2020-2027
TABLE 39 Asia Pacific Generic Injectables Market by Country Revenue, 2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
China XX XX XX XX XX XX XX XX
Japan XX XX XX XX XX XX XX XX
India XX XX XX XX XX XX XX XX
Korea XX XX XX XX XX XX XX XX
South East Asia XX XX XX XX XX XX XX XX
Rest of APAC XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
19.1.2 Asia Pacific Generic Injectables Market Size (2020-
2027)
FIG. 62 Asia Pacific Generic Injectables Market Share (%) by Country
(2020-2027)

100. 100
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
19.1.3 Asia Pacific Generic Injectables Market (USD Million)
Size by Type (2020-2027)
TABLE 40 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
19.1.4 Asia Pacific Generic Injectables Revenue Market Size
by Type 2022
FIG. 63 Asia Pacific Generic Injectables Revenue Market Size by Type
2022

101. 101
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
19.1.5 Asia Pacific Generic Injectables Market (USD Million)
Size by Application (2020-2027)
TABLE 41 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Oncology xx xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
19.1.6 Asia Pacific Generic Injectables Revenue Market Size
by Application 2022
FIG. 64 Asia Pacific Generic Injectables Revenue Market Size by
Application 2022

102. 102
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

103. 103
Global Generic Injectables Market 2020
Chapter 20 Latin America Generic Injectables Market
Forecast 2020-2027
20.1 Latin America
20.1.1 Latin America Generic Injectables Market by Country,
2020-2027
TABLE 42 Latin America Generic Injectables Market by Country Revenue, 2020-
2027
2020 2021 2022 2023 2024 2025 2026 2027
Brazil XX XX XX XX XX XX XX XX
Argentina XX XX XX XX XX XX XX XX
Columbia XX XX XX XX XX XX XX XX
Rest of Latin America XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
20.1.2 Latin America Generic Injectables Market Size (2020-
2027)
FIG. 65 Latin America Generic Injectables Market Share (%) by
Country (2020-2027)

104. 104
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
20.1.3 Latin America Generic Injectables Market (USD
Million) Size by Type (2020-2027)
TABLE 43 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
20.1.4 Latin America Generic Injectables Revenue Market Size
by Type 2022
FIG. 66 Latin America Generic Injectables Revenue Market Size by
Type 2022

105. 105
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
20.1.5 Latin America Generic Injectables Market (USD
Million) Size by Application (2020-2027)
TABLE 44 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Oncology xx xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
20.1.6 Latin America Generic Injectables Revenue Market Size
by Application 2022
FIG. 67 Latin America Generic Injectables Revenue Market Size by
Application 2022

106. 106
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

107. 107
Global Generic Injectables Market 2020
Chapter 21 Middle East and Africa Generic Injectables Market
Forecast 2020-2027
21.1 Middle East and Africa
21.1.1 Middle East and Africa Generic Injectables Market by
Country, 2020-2027
TABLE 45 Middle East and Africa Generic Injectables Market by Country Revenue,
2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
GCC Countries XX XX XX XX XX XX XX XX
Egypt XX XX XX XX XX XX XX XX
South Africa XX XX XX XX XX XX XX XX
Nigeria XX XX XX XX XX XX XX XX
Turkey XX XX XX XX XX XX XX XX
Rest of MEA XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
21.1.2 Middle East and Africa Generic Injectables Market Size
(2020-2027)
FIG. 68 Middle East and Africa Generic Injectables Market Share (%)
by Country (2020-2027)

108. 108
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
21.1.3 Middle East and Africa Generic Injectables Market
(USD Million) Size by Type (2020-2027)
TABLE 46 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Large Molecule Injectables (Biosimilars) xx xx xx xx xx xx xx Xx
Small Molecule Injectables xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
21.1.4 Middle East and Africa Generic Injectables Revenue
Market Size by Type 2022
FIG. 69 Middle East and Africa Generic Injectables Revenue Market
Size by Type 2022

109. 109
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis
21.1.5 Middle East and Africa Generic Injectables Market
(USD Million) Size by Application (2020-2027)
TABLE 47 North America Generic Injectables Market (USD Million) Size by Type
(2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Oncology xx xx xx xx xx xx xx Xx
Infectious Diseases xx xx xx xx xx xx xx Xx
Cardiology xx xx xx xx xx xx xx Xx
Diabetes xx xx xx xx xx xx xx Xx
Immunology xx xx xx xx xx xx xx Xx
Others xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
21.1.6 Middle East and Africa Generic Injectables Revenue
Market Size by Application 2022
FIG. 70 Middle East and Africa Generic Injectables Revenue Market
Size by Application 2022

110. 110
Global Generic Injectables Market 2020
Source: Secondary Research, Interviews, and Expert Analysis

111. 111
Global Generic Injectables Market 2020
Chapter 22 Research Findings and Conclusion
The global Generic Injectables market was valued at USD XX Million in year 2014
and is expected to reach USD XX Million by 2025.
On the basis of product type the market can be Segmented into Type 1, and Type
2. The Type 1 Segment accounted for major share in the market in 2017.
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

112. 112
Global Generic Injectables Market 2020